Market Updates
26/01/2021
Notes from the Trading Desk - Franklin Templeton

Franklin Templeton’s Notes from the Trading Desk offers a weekly overview of what their professional traders and analysts are watching in the markets. The European desk is manned by eight professionals based in Edinburgh, Scotland, with an average of 15 years of experience whose job it is to monitor the markets around the world. Their views are theirs alone and are not intended to be construed as investment advice.

The Digest

After a subdued start to last week (given a US bank holiday on 18 January), we saw mixed performance for global markets as US and Asian equities grinded higher, whilst European equities stalled. In the United States, there was much fanfare around the new administration, although little new to move the market. In Europe, the European Central Bank (ECB) meeting likewise did little to move the needle, but equities did fade on Friday on deteriorating sentiment regarding COVID-19 dynamics. On the week, we saw the STOXX Europe 600 Index +0.2%, S&P 500 Index +1.9%, MSCI Asia Pacific Index +2.1% and the MSCI World Index +1.5%.

COVID-19 Dynamics Remain in Focus

COVID-19 and the economic impact of prolonged lockdowns continues to be a driver for Europe’s markets. Whilst there are signs the hard-hit United Kingdom is turning a corner in terms of declining new cases, other European countries (such as Spain) are seeing increasing numbers and there seems little scope to ease lockdowns in the near term. Indeed, new restrictions have been implemented across the region in recent weeks amid the threat of new variants.

In that context, EU macro data continues to come in weaker than expected. The flash EU Purchasing Managers’ Index (PMI) hit a two-month low at 47.5 versus 49.1 prior. In the UK private sector, output hit an eight-month low of 40.6 versus 50.4 prior, both of which point to a double-dip recession in the United Kingdom and in Europe. In that context, the European Central Bank (ECB) kept policy unchanged last week, as expected.

Inevitably, the rollout of vaccines will be a key driver for markets, and any issues or delays will likely be a headwind for equities. For example, on Friday we saw a headline that AstraZeneca vaccine supplies to Europe faced some delay, and European equities declined that day. The vaccination program rollout and effectiveness of vaccines will be a key market dynamic for 2021.

Elsewhere, the picture in the United States shows some signs of improving, with the lowest number of new cases in eight weeks and emerging infections declining across all regions of the country, according to COVID-19 Tracking Project data. The new case level of 143,000 is the lowest figure since 01 December. In Asia, there have been some outbreaks, with Hong Kong locking down a district in Kowloon. Residents of an area of Shanghai have been banned from leaving the city, and Malaysia is extending lockdowns in most states.

As we enter fourth-quarter corporate earnings season, we will get more clarity on how the COVID-19 crisis has impacted the real economy.

Risk Correction Imminent? 

After the recent gains for equity markets in the fourth quarter and with a new US administration, the question of what’s next for markets is a focus now. The move higher on hope of US fiscal stimulus will likely become more of a ‘show-me’ mode as the proposed package makes its way through Congress.

There were some well-publicised comments from high-profile investors last week, with Baupost Group founder, Seth Klarman, warning that investors were disregarding market risks, similar to frogs being slowly brought to the boil. In addition, GMO founder Jeremy Grantham said the recent rally was an ‘epic bubble’.

However, many market observers remain positive on economic outlook, particularly in the United States. The impact of retail investing is important to keep in mind, if the US government does send US$1,400 cheques to millions of individuals.

Looking ahead, the risks related to the vaccine rollout and prolonged economic lockdowns are worth keeping in mind, and perhaps looking further out, the risk of taper tantrum as central banks look to eventually wean economies off the quantitative-easing sugar rush.

The Week in Review

Europe

European equity markets traded mixed for a second week running, struggling for any clear direction last week. The STOXX Europe 600 Index closed the week up slightly. It was a slow start to the week with US markets closed on 18 January for Martin Luther King Jr. Day, and volumes were much lower than average. COVID-19 lockdowns continue to be a key market overhang for now, with very little to suggest that restrictions will be eased in Europe any time soon.

US President Joe Biden’s inauguration came and went, but he signed a record 17 executive orders on his first day in office, which received some sector focus. European politics returned to the forefront somewhat as the Christian Democratic Union leadership vote in Germany passed without any drama. Meanwhile, Italian Prime Minister Giuseppe Conte won a couple of votes of confidence to continue governing without a majority.

The latest ECB policy announcements were largely as expected. Over the next couple of weeks, focus will shift to fundamentals as we head into a new corporate earnings season in Europe.

In terms of index moves last week, Germany’s DAX outperformed, up 0.6%, given strength in autos. At the other end, Spain’s IBEX underperformed, down 2.4%, given weakness in some of the heavyweight constituents, primarily in the travel and leisure and banks space.

Momentum stocks outperformed in Europe last week, whilst value stocks lagged. In terms of sectors, autos outperformed given stronger Chinese data earlier in the week, up 3.9%. Technology stocks were also better off, up 3.4% and buoyed by strength in the United States. Travel and leisure stocks lagged, down 2.8%, with COVID-19 lockdowns extended and travel corridors removed. Insurers also underperformed, down given the political uncertainty in Italy and with UK insurers already under pressure following last Friday’s decision by the Supreme Court in favour of the 370,000 businesses impacted by the pandemic.

Italian Politics

Italian Prime Minister Guiseppe Conte is under pressure to fill in the hole left by the exit of Renzi’s Italy Alive party over the government’s handling of the COVID-19 pandemic and could face new elections if he is unable to pull together a workable parliamentary majority. Conte narrowly won a confidence vote in the Senate on Tuesday, falling short of an absolute majority. He now faces another key vote in the upper house next week and has immediately got to work on trying to win over senators who did not vote for him on Tuesday (according to Italian media).

The chance of an election being called in the short term is still seen as low but remains a potential risk to sentiment given the uncertainty it would bring. Without a majority in the upper house, Conte will likely struggle to pass meaningful legislation, including annual budgets.

The spread between Italian and German 10-year bond yields widened on Friday as concerns mounted. Italian equities are underperforming as we kick off the new trading week. It’s worth noting that at the ECB meeting, President Christine Lagarde was asked about Italian government bonds and said that she doesn’t see any euro-area yield that poses a risk. This suggests the central bank is comfortable with the widening seen so far and appears unlikely to resist additional widening should we see further political upset in Italy. However, this is clearly unhelpful for the banks and insurers.

ECB: No Surprises and a Pragmatic ‘Wait and See’ Tone

As expected, no changes to any of the ECB’s policy settings in its latest meeting. If anything, Lagarde may have surprised a touch with her almost optimistic tone, notwithstanding the renewed wave of lockdowns. The ECB is sticking with previous baseline economic projections for 2021 as a whole, pointing to a number of positive factors which are countering the effect of the virus; i.e., vaccine rollout, avoidance of a hard Brexit, agreement of Next Generation fiscal stimulus (although this needs to be ratified by Parliaments), manufacturing resilience and finally, the removal of US political uncertainty.

Economic forecasts will be reviewed for the March ECB meeting, when there could be a bit more visibility on the progression of the pandemic. When pressed on policy options, the focus was on the Pandemic Emergency Purchase Program (PEPP). Lagarde was keen to stress that although purchases will continue until at least the end of March 2022, the programme could be recalibrated (increased) if needed. But, if a recovery comes through strongly, the full ‘envelope’ need not be used. The only time she sounded more cautious was when asked about the exchange rate. Here she said that the ECB is monitoring the exchange rate very carefully, that all instruments can be adjusted and that nothing is off the table. By the end of the meeting, the euro was unchanged and German bunds up by just 1 basis point.

United States

US equities traded broadly higher in a holiday-shortened week, with equity markets closed on Monday for Martin Luther King Jr. Day. It was a momentous day on Wednesday as Joe Biden was sworn in as 46th president. The NASDAQ outperformed on the week, up 4.4%, given the rotation into tech and growth stocks. The S&P 500 Index closed up 1.9%, whilst the Dow Jones Industrial Average lagged, up 0.6%. Fiscal stimulus, ultra-accommodative monetary policy and above-consensus earnings drove the market higher. In terms of sector moves, similar to Europe, tech was up (4.4%) on the week, but it was communications services which outperformed, up 6% on the week, given the strength in Facebook and Google. In terms of laggards, energy and financials were both down.

Earnings season is underway in the United States, with 122 companies in the S&P 500 reporting this week.

Once Biden was sworn in, he got to work immediately, signing several executive orders, including orders on immigration, the environment and coronavirus. Market sentiment remained optimistic, although there was nothing particularly market-moving. The new president will be laying out new vaccination plans as well as more executive actions to combat the virus in the days ahead, whilst also starting to negotiate the US$1.9 trillion stimulus bill that the administration released last week. Elsewhere, Amazon, a notable ‘winner’ from lockdown, has offered to help the Biden administration with vaccine distribution.

Relations with China remain a key focus for the Biden presidency. Janet Yellen, Biden’s pick to run the US Treasury, spoke of China’s ‘abusive’ practices, adding that the United States would be willing to ‘use the full array of tools’ and that there would be a comprehensive review of former President Trump’s ‘Phase-One’ trade deal. Biden’s defense secretary nominee, Lloyd Austin, added that China represented the US government’s ‘most significant challenge’.

Last week, Yellen also testified to Congress on a series of tax increases for corporations and high-net-worth Americans. Expectations were that tax increases would not come in until after the pandemic subsides, so markets were caught off-guard a little on Friday last week. She also defended the plans against criticism from Republicans who believe raising the corporate tax rate from 21% to 28% would make the US less competitive.

Asia and Pacific (APAC)

Equity markets were broadly higher last week, with the MSCI Asia Pacific Index closing the week up 2.2%. Positive Chinese fourth-quarter gross domestic product (GDP) data on Monday helped to support markets early in the week.

The Bank of Japan left rates unchanged as expected, but made marginal changes to GDP forecasts. Hong Kong’s Hang Seng Index outperformed on the week, up 3.1%, whilst Japan’s Nikkei lagged a bit, up just 0.4% as the number of seriously ill COVID-19 patients reached record levels in Japan. In terms of sectors, it was a similar story to the United States and Europe, with tech up 3.2% and communication services up 4.2%. But, it was consumer discretionary stocks which really led the way in Asia, up 5.5%. Financials were the only sector to finish in the red, down 1.4% on the week.

On Monday, it was reported that Chinese fourth-quarter 2020 GDP expanded at pre-pandemic levels amid strength in industrial production and exports. Meanwhile, retail sales and fixed-asset investment underwhelmed. China was expected to record the strongest GDP in a decade in 2021; however, activity is expected to slow given the recent increase in COVID-19 cases in China. Lockdown was extended in three cities in the Hebei province as authorities try to limit the spread ahead of the Lunar New Year holiday. It was also reported that Chinese authorities are discouraging movement around the country ahead of the celebrations, which are naturally expected to be a little more muted this year. Meanwhile, as mentioned, US-China trade relations continue to be fraught for reasons aplenty.

It was quiet in terms of data elsewhere. Nonetheless, Australian consumer sentiment showed a small drop in confidence this month. Japanese exports rose for the first time in two years, but imports remained weak.

Week Ahead

Eurozone fourth-quarter GDP figures will be worth watching for further clarity on the extent of the economic damage as lockdown restrictions tightened. Outside of Europe, the US Federal Open Market Committee (FOMC) statement on Wednesday will be closely watched. Commentary from the virtual Davos forum could give us some interesting snippets.

Monday 25 January

  • Germany IFO Business Climate.
  • The World Economic Forum’s ‘The Davos Agenda 2021’. Speakers include: Chinese President Xi Jinping, French President Macron and German Chancellor Angela Merkel.
  • EU foreign affairs ministers are set to discuss current issues affecting the bloc.
  • Key speakers: ECB’s Lane and Panetta.

Tuesday 26 January

  • UK Claimant Count & ILO Unemployment Rate; Spain PPI; US state employment; Japan Retail Sales.
  • The IMF releases its latest World Economic Outlook.
  • Key speakers: ECB’s Centeno.

Wednesday 27 January  

  • Germany Consumer Confidence; France Consumer Confidence, total jobseekers; US FOMC statement.
  • Key speakers: ECB’s Lane.

Thursday 28 January   

  • Spain unemployment rate; Italy Manufacturing and Consumer Confidence; Eurozone Consumer Confidence; Germany CPI; US GDP and Jobless Claims; Japan Jobless Rate and Industrial Production.
  • Key speakers: ECB’s Schnabel.

Friday 29 January   

  • France GDP, Consumer Spending PPI; Germany GDP, Unemployment Change; Spain GDP, CPI, CA Balance; Italy PPI.

 

 



Franklin Templeton Key risks & Disclaimers:

What Are the Risks?

All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments. Investments in developing markets involve heightened risks related to the same factors, in addition to those associated with their relatively small size and lesser liquidity. Past performance is not an indicator or guarantee of future performance.

This article reflects the analysis and opinions of Franklin Templeton’s European Trading Desk as of 25 January 2021, and may vary from the analysis and opinions of other investment teams, platforms, portfolio managers or strategies at Franklin Templeton. Because market and economic conditions are often subject to rapid change, the analysis and opinions provided may change without notice. An assessment of a particular country, market, region, security, investment or strategy is not intended as an investment recommendation, nor does it constitute investment advice. Statements of fact are from sources considered reliable, but no representation or warranty is made as to their completeness or accuracy. This article does not provide a complete analysis of every material fact regarding any country, region, market, industry or security. Nothing in this document may be relied upon as investment advice or an investment recommendation. The companies named herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. Data from third-party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user. Products, services and information may not be available in all jurisdictions and are offered by FT affiliates and/or their distributors as local laws and regulations permit. Please consult your own professional adviser for further information on availability of products and services in your jurisdiction. 

Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.



MeDirect Disclaimers:

This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment and may be deducted from the invested amount therefore lowering the size of your investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Why choose MeDirect?
We are a specialised bank, focused on providing market leading savings products, investment services and wealth management. With low and transparent fees, make the most of your wealth and open an account today.